Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML

Summary Bone marrow vascular niches sustain hematopoietic stem cells (HSCs) and are drastically remodeled in leukemia to support pathological functions. Acute myeloid leukemia (AML) cells produce angiogenic factors, which likely contribute to this remodeling, but anti-angiogenic therapies do not improve AML patient outcomes. Using intravital microscopy, we found that AML progression leads to differential remodeling of vasculature in central and endosteal bone marrow regions. Endosteal AML cells produce pro-inflammatory and anti-angiogenic cytokines and gradually degrade endosteal endothelium, stromal cells, and osteoblastic cells, whereas central marrow remains vascularized and splenic vascular niches expand. Remodeled endosteal regions have reduced capacity to support non-leukemic HSCs, correlating with loss of normal hematopoiesis. Preserving endosteal endothelium with the small molecule deferoxamine or a genetic approach rescues HSCs loss, promotes chemotherapeutic efficacy, and enhances survival. These findings suggest that preventing degradation of the endosteal vasculature may improve current paradigms for treating AML.

[1]  S. Heinzel,et al.  Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia , 2018, Leukemia.

[2]  W. Berdel,et al.  Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. , 2000, Blood.

[3]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[4]  G. Zheng,et al.  Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation. , 2015, Blood.

[5]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[6]  Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3 , 2010, The Journal of cell biology.

[7]  M. Headley,et al.  Visualization of immediate immune responses to pioneer metastatic cells in the lung , 2016, Nature.

[8]  S. Morrison,et al.  A perisinusoidal niche for extramedullary haematopoiesis in the spleen , 2015, Nature.

[9]  Philippe Dessen,et al.  Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia , 2010, The Journal of experimental medicine.

[10]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[11]  G. Rodgers,et al.  Evidence of increased angiogenesis in patients with acute myeloid leukemia. , 2000, Blood.

[12]  J. Folkman,et al.  gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice , 1995, The Journal of experimental medicine.

[13]  S. Ergün,et al.  Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. , 1997, Blood.

[14]  Daniel J Weisdorf,et al.  Acute Myeloid Leukemia. , 2015, The New England journal of medicine.

[15]  T. Enver,et al.  Leukemia propagating cells rebuild an evolving niche in response to therapy. , 2014, Cancer cell.

[16]  T. Lister,et al.  AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia. , 2010, Cancer research.

[17]  E. Currie,et al.  Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells. , 2013, Blood.

[18]  S. McColl,et al.  Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. , 1997, Journal of immunology.

[19]  J. Gribben,et al.  Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia , 2017, Cancer cell.

[20]  D. Rowe,et al.  Identification of differentially expressed genes between osteoblasts and osteocytes. , 2009, Bone.

[21]  F. Cavalli,et al.  A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia. , 2003, Blood.

[22]  L. Luo,et al.  A global double‐fluorescent Cre reporter mouse , 2007, Genesis.

[23]  R. Adams,et al.  Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.

[24]  G. Hannon,et al.  MaRX: An Approach to Genetics in Mammalian Cells , 1999, Science.

[25]  S. Armstrong,et al.  Myeloid progenitor cluster formation drives emergency and leukemic myelopoiesis , 2017, Nature.

[26]  I. Ong,et al.  GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells. , 2016, Cell reports.

[27]  H. Gerhardt,et al.  Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting , 2010, Nature Cell Biology.

[28]  R. Weichselbaum,et al.  Tumour ischaemia by interferon-γ resembles physiological blood vessel regression , 2017, Nature.

[29]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[30]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[31]  I. Roeder,et al.  In vivo time-lapse imaging shows diverse niche engagement by quiescent and naturally activated hematopoietic stem cells. , 2014, Blood.

[32]  Jon C. Aster,et al.  Essential Roles for Ankyrin Repeat and Transactivation Domains in Induction of T-Cell Leukemia by Notch1 , 2000, Molecular and Cellular Biology.

[33]  Satoshi Tanaka,et al.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.

[34]  S. Armstrong,et al.  Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. , 2014, Cell stem cell.

[35]  B. Porse,et al.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.

[36]  M. Cleary,et al.  Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. , 2006, Cancer cell.

[37]  I. Roeder,et al.  HEMATOPOIESIS AND STEM CELLS In vivo time-lapse imaging shows diverse niche engagement by quiescent and naturally activated hematopoietic stem cells , 2014 .

[38]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[39]  R. Johnstone,et al.  Lethal Giant Larvae 1 Tumour Suppressor Activity Is Not Conserved in Models of Mammalian T and B Cell Leukaemia , 2014, PloS one.

[40]  J. Teruya-Feldstein,et al.  Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. , 2014, Blood.

[41]  John F Markham,et al.  Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data , 2007, Nature Protocols.

[42]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Angela C. Colmone,et al.  Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells , 2008, Science.

[44]  Malgorzata Nowicka,et al.  T cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments , 2016, Nature.

[45]  S. Fukuda,et al.  The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. , 2007, Blood.

[46]  Zev Rosenwaks,et al.  Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. , 2009, Cell stem cell.

[47]  J. Gribben,et al.  Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation , 2013, Proceedings of the National Academy of Sciences.

[48]  E. Estey,et al.  Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. , 2000, Blood.

[49]  C. Lo Celso,et al.  In Vivo 4-Dimensional Tracking of Hematopoietic Stem and Progenitor Cells in Adult Mouse Calvarial Bone Marrow , 2014, Journal of visualized experiments : JoVE.

[50]  S. Butz,et al.  Flow Dynamics and HSPC Homing in Bone Marrow Microvessels , 2017, Cell reports.

[51]  David W. Rowe,et al.  Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche , 2009, Nature.

[52]  Stephan Saalfeld,et al.  Software for bead-based registration of selective plane illumination microscopy data , 2010, Nature Methods.

[53]  M. Bixel,et al.  Blood flow controls bone vascular function and osteogenesis , 2016, Nature Communications.

[54]  E. Vellenga,et al.  Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK). , 2012, Blood.

[55]  A. Ferrando,et al.  CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance. , 2015, Cancer cell.

[56]  C. Betsholtz,et al.  Age-dependent modulation of vascular niches for haematopoietic stem cells , 2016, Nature.

[57]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[58]  E. Hsiao,et al.  Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. , 2013, Cell stem cell.

[59]  M. Spitaler,et al.  Automated Identification and Localization of Hematopoietic Stem Cells in 3D Intravital Microscopy Data , 2015, Stem cell reports.

[60]  Y. Saunthararajah,et al.  AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. , 2013, Blood.

[61]  S. Morrison,et al.  The bone marrow niche for haematopoietic stem cells , 2014, Nature.

[62]  W. Berdel,et al.  Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity , 2007, Leukemia.

[63]  R. Adams,et al.  Endothelial Notch activity promotes angiogenesis and osteogenesis in bone , 2014, Nature.